Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Interest & Investment Income of $3.0 million for Q1 2026, down 25.0% year-over-year from $4.0 million in Q1 2025, and down 50.0% quarter-over-quarter from $6.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 25.0% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $21.0 million (up 5.0% YoY), while the FY2025 annual figure was $22.0 million, down 4.35% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.0 million, down from $6.0 million in the prior quarter.
- The five-year high for Interest & Investment Income was $7.0 million in Q1 2024, with the low at $3.0 million in Q1 2026.
- The 3-year median for Interest & Investment Income is $6.0 million (2024), against an average of $5.3 million.
- Peak annual rise in Interest & Investment Income reached 20.0% in 2025, while the deepest fall reached 42.86% in 2025.
- Indivior Pharmaceuticals' Interest & Investment Income stood at $5.0 million in 2024, then rose by 20.0% to $6.0 million in 2025, then slumped by 50.0% to $3.0 million in 2026.
- Business Quant data shows INDV's Interest & Investment Income at $3.0 million in Q1 2026, $6.0 million in Q4 2025, and $6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.60 Bn | 4.38 Bn | 294.00 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 6.00 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 7.00 Mn |